Navigation Links
Pro-Dex, Inc. Announces Fiscal 2013 Fourth Quarter And Full-Year Results
Date:9/25/2013

60;30, 2013 and 2012, respectively

17,012,000

16,846,000Accumulated other comprehensive income

5,000

—Accumulated deficit

(9,080,000)

(7,296,000)  Total shareholders' equity

7,937,000

9,550,000Total liabilities and shareholders' equity

$10,595,000

$  12,822,000 PRO-DEX, INC. and SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSSFor The Years Ended June 30,20132012Net sales

$  12,249,000

$  17,257,000Cost of sales

8,533,000

11,841,000Gross profit

3,716,000

5,416,000Operating expenses:Selling expenses

1,255,000

1,531,000General and administrative expenses

2,566,000

3,182,000Research and development costs

1,790,000

2,068,000Total operating expenses

5,611,000

6,781,000Loss from continuing operations before items below

(1,895,000)

(1,365,000)Other income (expense):Interest income

3,000

—Interest expense

(11,000)

36,000Total other expense

(8,000)

(36,000)Loss from continuing operations before provision for income taxes

(1,903,000)

(1,401,000)Benefit from income taxes

(39,000)

(441,000)Loss from continuing operations

(1,864,000)

(960,000)Income from discontinued operations, net of income taxes of $51,000 in 2013 and net of benefit for income taxes of $146,000 in 2012

80,000

84,000Net loss

$   (1,784,000)

$
(876,000)Other comprehensive income, net of taxUnrealized gain from marketable equity investments

5,000

—  Total other comprehensive income

5,000

—Comprehensive loss

$   (1,779,000)

$
(876,000)Per share data (basic and diluted):Loss from cont
'/>"/>

SOURCE Pro-Dex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
2. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
3. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
4. Pro-Dex, Inc. Announces Update Conference Call and Webcast
5. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
6. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter And Full-Year Results
7. Pro-Dex, Inc. Announces Fiscal 2013 First Quarter Results
8. Pro-Dex, Inc. Announces Fiscal Second Quarter And Six-Month Results
9. Pro-Dex, Inc. And AO Partners Group Jointly Announce Voting Results
10. Pro-Dex, Inc. Appoints Harold A. Hurwitz Chief Executive Officer
11. Pro-Dex, Inc. Appoints Richard Van Kirk Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Insulin ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong ...
(Date:1/15/2014)... , Jan. 15, 2014 ... research report is available in its ... Markets and Technologies for Advanced Drug ... of Administration ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
... EPODURE Biopump demonstrates safety and efficacy for four months ... Review Board confirms safety and efficacy of low dose ... trial with higher doses-- Biopump may offer alternative to ... Medgenics (AIM: MEDU/MEDG), today announced that the EPODURE ...
... FRANCISCO, Calif., Feb. 3 Rigel,Pharmaceuticals, Inc. (Nasdaq: ... will delay,further partnership discussions regarding R788 until after ... are available. The company expects that,these ... the understanding of R788,s potential and may therefore,drive ...
Cached Medicine Technology:Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease 2Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease 3Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease 4Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease 5Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 2Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 3Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 4Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 5
(Date:4/17/2014)... N.C. April 17, 2014 Meaningful long-term ... advanced cancer of the abdomen when treated with ... according to a first-of-its-size analysis by physicians at ... Baptist has the largest reported, single-center experience with ... A. Levine, M.D., and analysis of 20 years, ...
(Date:4/17/2014)... India,s shocking rates of suicide are highest in areas ... tiny smallholdings less than one hectare and ... coffee, that are highly susceptible to global price fluctuations. ... studies that point to a crisis in key areas ... nation,s economy during the 90s. Researchers say that policy ...
(Date:4/17/2014)... Professor Patrick Johnston, whose work has transformed cancer care ... of the European Academy of Cancer Sciences., The Academy, ... body of highly distinguished oncologists and cancer researchers which ... cancer in Europe. , Professor Johnston, whose leadership has ... the bottom of the UK league table to near ...
(Date:4/16/2014)... Consider the marvel of the embryo. It begins as a ... they multiply to become the cells of our lungs, muscles, ... , Now, in a feat of reverse tissue engineering, Stanford ... that allows embryonic cells to proliferate and transform into all ...
(Date:4/16/2014)... A team that includes scientists from the School of ... San Antonio, Johns Hopkins University and St. Mary,s University reported ... to infect the body. , The fungal pathogen Candida ... and is the most common fungal pathogen to infect humans. ...
Breaking Medicine News(10 mins):Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3
... The drug flibanserin, which was originally created as an ... results from three separate clinical trials have found. These ... works at the level of the brain to enhance libido ... Jr., M.D., McAllister distinguished professor of obstetrics and gynecology at ...
... , RALEIGH, N.C., Nov. 16 Blue Water Spa, a ... in Raleigh with an anniversary party and Raleigh food drive. Guests ... tickets. One lucky winner will receive a $10,000 spa gift certificate ... Shuttle of NC will be on hand Wed. November 18 and ...
... , SINGAPORE, Nov. 16 /PRNewswire-Asia/ -- ... grew steadily in the first half of 2009 with,total consumption ... from major Contact Lens manufacturers. Positive sales,data showing a growth ... of an economic recovery that is being led by consumers ...
... NEW YORK, Nov. 16 Nearly every household has some sort ... the like. But how many people plan ahead for dental emergencies? ... a leading provider of oral care products, although one in six ... were not prepared to deal with the problem. , "You ...
... ... theory and experiments in quantum mechanics - it says there is no solidity or ... in time. This could change science, medicine, religion, economics; and create world peace, eternal life ... (PRWEB) ...
... ... tools for cognitive impairments caused by Alzheimer,s disease, Traumatic Brain Injury, ADD, Schizophrenia and ... (PRWEB) ... online cognitive rehab tools for a variety of cognitive disorders at the ...
Cached Medicine News:Health News:Viagra for women? Drug developed as antidepressant effective in treating low libido 2Health News:Raleigh Day Spa, Blue Water Spa, Raffles Off $10,000 in Day Spa Packages for Contributing to Raleigh Food Drive 2Health News:GfK Asia Reports: Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 2Health News:GfK Asia Reports: Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 3Health News:Be Prepared for a Dental Emergency During the Holidays 2Health News:New View Of Reality (In Printed Book Form) That Combines Einstein And Quantum Mechanics, And Fills The World With Miracles 2Health News:New View Of Reality (In Printed Book Form) That Combines Einstein And Quantum Mechanics, And Fills The World With Miracles 3Health News:HAPPYneuron Launches Beta Program for Innovative Cognitive Rehab Tools at AMIA Conference in San Francisco 2Health News:HAPPYneuron Launches Beta Program for Innovative Cognitive Rehab Tools at AMIA Conference in San Francisco 3
Ergotec Vetriretinal Instrument System. Extra fine angled tips (3 mm). 20 ga. shaft tapering to 23 ga., 10 mm from tip. Overall length from rear rotation knob to tip....
Ergotec Vetriretinal Instrument System. Ultra-fine 3.35 mm tips. Angled 55 degrees. 20 gauge shaft. 30 mm in length. Overall length from rear rotation knob to tip....
For use with the Landers Vitrectomy Lens set (MVS 1079A). Shafts angled 45 degrees with curved grooved blades for holding the Landers vitrectomy lenses. Polished finish....
Ergotec Vetriretinal Instrument System. 2 mm pointed tips with 0.6 mm platform. 20 gauge shaft tapers to 23 gauge....
Medicine Products: